Grade 3/4 neutropenia is a limiting factor in second-line FOLFIRI following FOLFOX4 failure in elderly patients with metastatic colorectal cancer

Previous studies have reported improved outcomes for elderly patients with metastatic colorectal cancer (mCRC) treated with oxaliplatin or irinotecan as first-line chemotherapy. However, few studies regarding second-line chemotherapy with oxaliplatin or irinotecan are currenlty available. We analyze...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: KUBOKI, YASUTOSHI, MIZUNUMA, NOBUYUKI, OZAKA, MASATO, OGURA, MARIKO, SUENAGA, MITSUKUNI, SHINOZAKI, EIJI, MATSUSAKA, SATOSHI, CHIN, KEISHOU, MATSUURA, MASAAKI, HATAKE, KIYOHIKO
Формат: Artigo
Язык:Inglês
Опубликовано: D.A. Spandidos 2011
Предметы:
Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3410456/
https://ncbi.nlm.nih.gov/pubmed/22866109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.260
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы